Statistician, MRC-CTU at UCL. Hiker, skier, guitarist, russian literature lover. Views are nice from my window.
London, England
Joined July 2018
- Tweets889
- Following529
- Followers853
- Likes1.2K
Matteo Quartagno retweeted
Hot off the press! 📣📣In this tutorial we illustrate available multiple imputation approaches for handling longitudinal data including when they are clustered within higher level clusters. A reproducible example with R and Stata code provided! #OpenAccess onlinelibrary.wiley.com/doi/… – at Melbourne, Victoria
Matteo Quartagno retweeted
For me, @Brennan_Kahan is one of the best speakers and writers in the field of medical statistics. I always enjoy reading his articles and listening to his talks. Another fantastic talk from him at #ICTMC2024 on different intercurrent strategies.
My first blog in ~4 years (!) and perhaps my last tweet (moving to the SoMe that talks about the colour of the sky): this is about the unlikely mashup of an Aesop fable and a paper from @timpmorris.bsky.social, @maartenvsmeden.bsky.social and Tra Pham.
theupperquartile.wixsite.com…
Matteo Quartagno retweeted
#ICTMC2024 starts on Monday, and our #ClinicalTrials methodology researchers will present a variety of talks, posters & workshops.
📍Are you heading to Edinburgh next week? Don't miss out - find a schedule of our appearances throughout the conference: bit.ly/3N4vanG
ALT Schedule of MRC Clinical Trials Unit at UCL oral presentations at ICTMC 2024. Please visit https://bit.ly/3N4vanG for details.
ALT List of MRC Clinical Trials Unit at UCL posters at ICTMC 2024. Please visit https://bit.ly/3N4vanG for details.
ALT List of MRC Clinical Trials Unit at UCL posters at ICTMC 2024. Please visit https://bit.ly/3N4vanG for details.
ALT Schedule of MRC Clinical Trials Unit at UCL workshops at ICTMC 2024. Please visit https://bit.ly/3N4vanG for details.
Matteo Quartagno retweeted
📢 Our paper on prevalence of #NCDs among household contacts of individuals with #tuberculosis is out in @TMIHjournal!
Using data from 29,194 contacts we show a high prevalence of undiagnosed #diabetes among contacts.
Thanks to all coauthors & collaborators!
@UCLGlobalHealth
Matteo Quartagno retweeted
*Using Simulation Studies to Evaluate Statistical Methods* by @tmorris_mrc & @stats_q
🗓️ 10 – 11 Oct 2024
🏢 Online
🌐 bit.ly/SimulationStudies_Sta…
Matteo Quartagno retweeted
Looking forward to speaking at the 4th International Global Academy of Women's Cancer Meeting on July 5/6 in Munich, Germany 🇩🇪
More info below 👇🏽
global-academy-of-womens-can…
Matteo Quartagno retweeted
Our new approach to non-inferiority #ClinicalTrials explicitly considers whether the new intervention is to be an “alternative” or a “replacement” to standard-of-care.
Find out how this could help move new therapies into widespread use more quickly👇
bmj.com/content/385/bmj-2023…
Matteo Quartagno retweeted
🆕25 at 25: We develop openly-available, user-friendly software packages to encourage researchers to implement our novel methods.
Discover how our statistical software helps improve #ClinicalTrials & #MetaAnalysis globally.
More details👉bit.ly/4cgwxKM #StatsTwitter
Matteo Quartagno retweeted
🧵We are proud to have had our PediCAP and NeoIPC teams share results at ESCMID Global! 👏
Follow along for some of the results shared!
#ESCMIDGlobal2024 #PediCAP #NeoIPC
Matteo Quartagno retweeted
**New tutorial (PREPRINT)**
We review multiple imputation approaches for handling incomplete longitudinal data (including the case with higher-level clusters), summarize available guidance and illustrate implementation (R and Stata)
#epitwitter #rstats
arxiv.org/abs/2404.06967
Matteo Quartagno retweeted
🚨New podcast episode out now and it's all about #MetaAnalysis!
@petegodolphin & @pgd81 discuss the new ‘within-trial framework for subgroup analysis', to work out which #ClinicalTrials participants benefit most from a treatment.
🎧Listen now: bit.ly/43boETF
We are giving an online workshop on Simulation Studies to Evaluate Stats Methods for GESIS in October. Needless to say, with @tmorris_mrc!
*Using Simulation Studies to Evaluate Statistical Methods* by @tmorris_mrc & @stats_q.
🗓️ 10 - 11 October 2024
🏢 Online
🌐bit.ly/SimulationStudies_Sta…
Matteo Quartagno retweeted
100th participant recruited to the REFINE-Lung study!! Thanks to all patients and carers who've supported, hard working sites and amazing clinical trials teams @MRCCTU @ImperialSandC @stats_q @MaxParmarMRCUCL #lungcancer #Immunotherapy
Matteo Quartagno retweeted
Have you checked out our @MRCCTU @ucl Trial Talk Podcast? If not check it out and give us a follow 👇
soundcloud.com/trial-talk-po…
#TrialTalkPodcast #ClinicalTrials
Matteo Quartagno retweeted
New preprint 📝 Multiple imputation of missing data in large studies with many variables: A fully conditional specification approach using partial least squares.
Preprint: osf.io/preprints/psyarxiv/47…
OSF-Repo: osf.io/5wqz2/
Matteo Quartagno retweeted
📽️NEW VIDEO 📽️
"How to get your article rejected by the BMJ:
12 common statistical issues"
I discuss common stats issues we encounter at @bmj_latest
Please check before you submit next article 🫣
Santa would check the list twice 🎅
Hope helpful 🙏
youtube.com/watch?v=iu4VsEv1…
Matteo Quartagno retweeted
Cluster randomized controlled trial analysis at the cluster level: The clan command - Jennifer A. Thompson, Baptiste Leurent, Stephen Nash, Lawrence H. Moulton, Richard J. Hayes, 2023 journals.sagepub.com/doi/ful…
Matteo Quartagno retweeted
Do you know what to do when your simulation study results aren't what you expected?
A new paper from @IanWhit25399993, @t_mpham, @stats_q & @tmorris_mrc gives guidance on preventing errors to improve the quality of published simulation studies👇
bit.ly/3uktSz3